Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Hironaga, Satake"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract To report the efficacy of anamorelin in patients with colorectal and gastric cancer with cachexia and in those receiving systemic chemotherapy. We retrospectively collected real-world data from patients diagnosed with colorectal and gastric
Externí odkaz:
https://doaj.org/article/0d386e630c9c45d795e213ed4e210345
Autor:
Tomohiro Yabushita, Yoshimitsu Shimomura, Hayato Maruoka, Daisuke Katoh, Daisuke Yamashita, Hironaga Satake, Nobuhiro Hiramoto, Satoshi Yoshioka, Noboru Yonetani, Momoko Nishikori, Takeshi Morimoto, Yukihiro Imai, Takayuki Ishikawa
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 698-708 (2024)
Abstract Somatic hypermutations (SHMs) in the variable region (VH) of the immunoglobulin heavy chain (IgH) gene are common in diffuse large B‐cell lymphoma (DLBCL). Recently, IgH VH SHMs have become known as immunogenic neoantigens, but few studies
Externí odkaz:
https://doaj.org/article/b22f7b1979c24583aac4b6c56dc70b75
Autor:
Hiroki Osumi, Eiji Shinozaki, Yoshiaki Nakamura, Taito Esaki, Hisateru Yasui, Hiroya Taniguchi, Hironaga Satake, Yu Sunakawa, Yoshito Komatsu, Yoshinori Kagawa, Tadamichi Denda, Manabu Shiozawa, Taroh Satoh, Tomohiro Nishina, Masahiro Goto, Naoki Takahashi, Takeshi Kato, Hideaki Bando, Kensei Yamaguchi, Takayuki Yoshino
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract “NeoRAS WT” refers to the loss of RAS mutations (MTs) following first-line treatment in metastatic colorectal cancer (mCRC). We evaluate the incidence and clinicopathological characteristics of NeoRAS WT mCRC using next-generation sequen
Externí odkaz:
https://doaj.org/article/32159db2ff3a4f6f8eaee8f39adf3f96
Autor:
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Yoshinori Kagawa, Naoki Takahashi, Tadamichi Denda, Taito Esaki, Hisato Kawakami, Hironaga Satake, Atsuo Takashima, Nobuhisa Matsuhashi, Takeshi Kato, Chiharu Asano, Yukiko Abe, Shogo Nomura, Takayuki Yoshino
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18702-18716 (2023)
Abstract Background Several biomarkers have been established for metastatic colorectal cancer (mCRC). We investigated whether plasma angiogenesis factors could predict the efficacy of biologics combined with chemotherapy in first‐line (1L) treatmen
Externí odkaz:
https://doaj.org/article/3ebebc37f7d94a9b970dc82f9c2f0539
Autor:
Chihiro Sato, Hisato Kawakami, Ryo Tanaka, Hironaga Satake, Kentaro Inoue, Yutaka Kimura, Junya Fujita, Ryohei Kawabata, Yasutaka Chiba, Taroh Satoh, Kazuhiko Nakagawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Adjuvant S-1 monotherapy is the standard of care for stage II gastric cancer (GC) after curative resection in Japan, but its efficacy for microsatellite instability–high (MSI-H) tumors has remained unknown. Among a multi-institutional coho
Externí odkaz:
https://doaj.org/article/530edf29753342e095c74eb7211e943c
Autor:
Toshinori Kobayashi, Yuki Matsui, Hisanori Miki, Masahiko Hatta, Mitsuaki Ishida, Hironaga Satake, Mitsugu Sekimoto
Publikováno v:
Surgical Case Reports, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Background Malignant tumors with rhabdoid features are rare, highly aggressive, and some of them are characterized by SMARCB1 (INI1) loss. Although cases of rhabdoid carcinoma are extremely rare, its occurrence in the colon has been reported
Externí odkaz:
https://doaj.org/article/1838dbe3e6ce48a08fc71872b9aa1e05
Autor:
Akira Ooki, Satoshi Morita, Akihito Tsuji, Shigeyoshi Iwamoto, Hiroki Hara, Hiroaki Tanioka, Hironaga Satake, Masato Kataoka, Masahito Kotaka, Yoshinori Kagawa, Masato Nakamura, Tatsushi Shingai, Masashi Ishikawa, Yasuhiro Miyake, Takeshi Suto, Yojiro Hashiguchi, Taichi Yabuno, Masahiko Ando, Junichi Sakamoto, Kensei Yamaguchi
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Purpose Although early tumor shrinkage (ETS) is a predictor of improved overall survival (OS), the association between ETS and health-related quality of life (HRQOL) remains unclear for patients with metastatic colorectal cancer (mCRC) treat
Externí odkaz:
https://doaj.org/article/8e277a2749b9411aa5325e80e6e2203a
Autor:
Tomofumi Miura, Ayumi Okizaki, Hideaki Hasuo, Eriko Satomi, Keita Tagami, Kengo Imai, Takashi Kojima, Hironaga Satake, Hiroto Ishiki, Akira Inoue, Takuhiro Yamaguchi
Publikováno v:
Palliative Medicine Reports, Vol 2, Iss 1, Pp 316-323 (2021)
Objective: No standard treatment for cancer-related fatigue (CRF) for inpatients in a palliative care setting exists. The aim of this study was to validate the previous study-derived efficacy of dexamethasone 8?mg for CRF among inpatients in a pallia
Externí odkaz:
https://doaj.org/article/b266c5bc381a45c59fbc27289dff3790
Autor:
Terufumi Yoshida, Hisanori Miki, Hironaga Satake, Toshinori Kobayashi, Yuuki Matsumi, Madoka Hamada, Shogen Boku, Nobuhiro Shibata, Mitsuaki Ishida, Mitsugu Sekimoto
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1497-1504 (2021)
Preoperative chemotherapy is efficacious in several cancers. However, it is not an established treatment for locally advanced colon cancer, particularly cases with microsatellite instability-high (MSI-H)/deficient mismatch repair. Herein, we report a
Externí odkaz:
https://doaj.org/article/e7a84401824a45099d4f19737302b62b
Autor:
Toshihiko Matsumoto, Shogo Yamamura, Tatsuki Ikoma, Yusuke Kurioka, Keitaro Doi, Tomoyo Yasuda, Shogen Boku, Takashi Kawai, Nobuhiro Shibata, Hiroki Nagai, Takao Tsuduki, Takanobu Shimada, Yusuke Matsumoto, Takehiko Tsumura, Masahiro Takatani, Hisateru Yasui, Hironaga Satake
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Background: A trial with trifluridine/tipiracil (FTD/TPI) versus placebo in patients with heavily pretreated metastatic gastric cancer showed that FTD/TPI is effective with manageable toxicity in these patients. However, real-world data on the effect
Externí odkaz:
https://doaj.org/article/6d5c257c05f04838a9c61c5e4a6e0026